Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Finasteride reduces hair growth and is safe for women with excessive hair.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

An extra-strength marine protein supplement helped increase hair growth and decrease hair shedding in women with thinning hair.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Women with PCOS have more emotional and body image issues than healthy women.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Antiandrogen therapy helps treat genetic hair loss.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.